Page last updated: 2024-08-16

mitomycin and cyclin d1

mitomycin has been researched along with cyclin d1 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Habuchi, T; Higashi, S; Ito, M; Kamoto, T; Nishiyama, H; Ogawa, O; Tsuchiya, N; Wang, L; Watanabe, J1
Guan, HG; Li, C; Li, P; Qian, HX; Qin, L; Wang, ZW; Xue, WJ; Zhou, XJ1
Liu, XJ; Lu, YY; Su, SB; Wang, XF; Zhang, H; Zhou, QM1
Jiao, M; Li, C; Mei, N; Tian, T; Zhao, N1

Other Studies

4 other study(ies) available for mitomycin and cyclin d1

ArticleYear
Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer.
    Urology, 2004, Volume: 64, Issue:1

    Topics: Aged; Alternative Splicing; Antineoplastic Agents, Alkylating; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Combined Modality Therapy; Cyclin D1; Cystectomy; Disease Progression; Female; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Humans; Immunotherapy, Active; Incidence; Life Tables; Male; Middle Aged; Mitomycin; Polymorphism, Genetic; Prognosis; Proportional Hazards Models; Proto-Oncogenes; Risk; Salvage Therapy; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms

2004
RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Journal of gastroenterology and hepatology, 2008, Volume: 23, Issue:9

    Topics: Adult; Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; China; Cyclin D1; DNA Replication; Female; Gene Expression Regulation, Neoplastic; Hepatitis B; Hepatitis B Surface Antigens; Humans; Liver Neoplasms; Logistic Models; Male; Mice; Mice, Nude; Mitomycin; Mutation; Odds Ratio; Risk Assessment; Risk Factors; Time Factors; Transfection; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays

2008
Curcumin enhanced antiproliferative effect of mitomycin C in human breast cancer MCF-7 cells in vitro and in vivo.
    Acta pharmacologica Sinica, 2011, Volume: 32, Issue:11

    Topics: Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Curcumin; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Mitomycin

2011
Biological features, gene expression profile, and mechanisms of drug resistance of two- and three-dimensional hepatocellular carcinoma cell cultures.
    Pharmacology research & perspectives, 2021, Volume: 9, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Cisplatin; Cyclin D1; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Minichromosome Maintenance Complex Component 2; Minichromosome Maintenance Complex Component 3; Mitomycin; Paclitaxel; Transcriptome

2021